If you are a patient who may have experience with planned cross-border healthcare in another EU Member State, Norway, Iceland or Liechtenstein in the last four years, you are kindly invited to participate in a study on enhancing information provision to patients in cross-border health services. This study is being conducted by Ecorys, Gfk and the University of Leuven on behalf of the European Commission.

One objective of the study is to explore patients’ experiences with gathering information on cross-border healthcare. By doing this they want to provide a better understanding of the importance of good information provision to patients during the process of planned medical treatment abroad. 

The survey is completely anonymous. Please do not provide any personal data. Participation in this study is voluntary. You are free to leave the survey page and withdraw your participation at any time. You are free to decline to answer any particular question you do not wish to answer for any reason.

Survey

Ever since the introduction of the EU directive 2011/24/UE on cross boarder healthcare, patients have faced numerous questions.

To respond to the various requests, within the framework of its operational activities, the Patiente Vertriedung asbl hosts a monthly information and counselling session, where an expert answers your questions.

The next conselling session takes place, tuesday the 3rd of october 2017.

According to the ministerial decision from June 26^th 2017 the statuary changes of the national health fund were approved and will be valid from 1^st of July.

Immediately effective the S2 form, request for prior approval of a cross boarder transfer, will once more be issued for consultations. This means that patients can again get a refund of their travel expenses.